Cytokine Inhibitors For Autoimmunity Set To Reach $11 Billion D In 2009-Blockbuster Protein Drugs Shaping The Standard Of Care For Autoimmune Diseases
The last few years has brought hope and relief to autoimmune disease patients, as new recombinant proteins that work directly on immune system effector cells have entered the marketplace. The current generation of biological response modifiers (BRMs), a group that includes Enbrel, Humira and Remicade, are quickly becoming the gold standard of care for some of the most common forms of arthritis, including rheumatoid arthritis and psoriatic arthritis. [click link for full article]
Knee Pain
Title: Knee Pain
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 7/19/2007
Gene Linked to Restless Leg Syndrome Found
Title: Gene Linked to Restless Leg Syndrome Found
Category: Health News
Created: 7/19/2007 2:00:00 AM
Last Editorial Review: 7/19/2007
